Riccio, M <br/><br/>
Nuclear localization of cystatin B, the cathepsin inhibitor implicated in myoclonus epilepsy (EPM1).  [electronic resource] 

 -  Experimental cell research  Jan 2001 
 - 84-94 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-4827 
<br/><br/><label>Standard No.: </label>10.1006/excr.2000.5085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cathepsin B--antagonists & inhibitors<br/>Cell Compartmentation<br/>Cell Differentiation--drug effects<br/>Cell Division--drug effects<br/>Cell Nucleus--metabolism<br/>Cells, Cultured<br/>Cerebellum--cytology<br/>Cystatin B<br/>Cystatins--metabolism<br/>Cytoplasm--metabolism<br/>Cytoskeleton--metabolism<br/>Epilepsies, Myoclonic--etiology<br/>Fluorescent Antibody Technique<br/>Humans<br/>Immunohistochemistry<br/>Muscle, Skeletal--cytology<br/>Nerve Growth Factor--pharmacology<br/>Neuroblastoma--metabolism<br/>Neurons--cytology<br/>Nuclear Matrix--metabolism<br/>Osteosarcoma--metabolism<br/>Rats<br/>Rats, Sprague-Dawley